Year All202620252024202320222021 Jun 11, 2026 Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026 Jun 05, 2026 Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development May 26, 2026 Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026 May 14, 2026 Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress May 12, 2026 Climb Bio to Present at Upcoming Investor Conferences May 07, 2026 Climb Bio Reports First Quarter 2026 Financial Results and Provides Business Updates
